if there was a real belief in the 50% chance as you say even in...

First 41 Last

Share
Profile

Follow
resourceboom

872 Posts.

14

16/12/22

20:32

Post #: 65347673
Share

Originally posted by needle: ↑

There are aspects of this company, its drug, its share price....that I do believe are seen once in a lifetime (of investing).

Melodramatic ? and maybe words of others even used from time to time, with their stock investment - but oh no, this is different.

The previous post - beyond any doubt whatsoever highlights what the potential of PI3K and radiation. Only paxalisib - only paxalisib is in clinical studies in this combination. You know the published results so far - millions of cancer patients are prescribed radiation every day.

-----------------------------------------
So what do you think - is the situation here unprecedented FOR A US$10 MILLION COMPANY ? or what.

Also I can't be bothered to further explain - but there is a 50% chance in 9 months -the company will seek approval to market this drug paxalisib for GBM (first new drug for GBM in 15 years). At a likely gross annual sale of US$600m- profit US$300m means the drug would be worth US$3 BILLION for GBM.
-----------------------------------------------------------------------------------------------

Still investing at 90 years of age - I don't think you will see this situation again.

Expand

if there was a real belief in the 50% chance as you say even in current conditions it should be easy for the company to raise through a white knight investor 20 to 50 mill at a 40 to 100 mill valuation.

so either the company reps are completely incompetent in their duties, or you are way off with optimism!

KZA Price at posting: 8.7¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

HIQ

HIT IQ has US patent for concussion management tech approved

EQN

Equinox finds REEs up to 10,110 at surface in Brazil, notes possible titanium dioxide project

ION

Iondrive confirms viability of battery recycling tech through bench trials

BMO

Bastion Minerals acquiring Canadian copper portfolio – but thanks to China, prices are sinking

RCR

Market shrugs at Rincon's latest copper drill hits – with management uncharacteristically honest for an ASX explorer